TY - JOUR T1 - Sex differences in the associations between risk for late-life AD, protective lifestyle factors and cognition in mid-life JF - medRxiv DO - 10.1101/2023.01.09.23284340 SP - 2023.01.09.23284340 AU - Qing Qi AU - Feng Deng AU - Karen Ritchie AU - Graciela Muniz-Terrera AU - Ivan Koychev AU - Paresh Malhotra AU - John T. O’Brien AU - Craig W. Ritchie AU - Brian Lawlor AU - Lorina Naci Y1 - 2023/01/01 UR - http://medrxiv.org/content/early/2023/01/10/2023.01.09.23284340.abstract N2 - It is now acknowledged that Alzheimer’s Disease (AD) processes are present decades before the onset of clinical symptoms, but whether lifestyle activities can protect against these early AD processes in mid-life remains poorly understood. Furthermore, the impact of sex as a biological variable on associations between dementia risk, protective lifestyle activities and cognition is unknown. In this study, we aimed to replicate findings from our two recent studies [Deng et al. (2022) and Heneghan et al. (2022)] on the contribution of mid-life modifiable activities to cognition in individuals with dementia risk, in a larger independent cohort of the PREVENT–Dementia research program (N = 461 vs N = 208 used previously). Second, we investigated associations between biological sex, dementia risk, protective lifestyle activities and cognitive performance. Participants (40–59 years; N = 461) completed cognitive and clinical assessments cross-sectionally. Mid-life activities were measured with the Lifetime of Experiences Questionnaire. Known risk factors for sporadic late-onset AD (Apolipoprotein E Ɛ4 allele status, family history of dementia, and the Cardiovascular Risk Factors Aging and Dementia score [CAIDE]) were investigated. Replicating our key previous findings (Deng et al., 2022 and Heneghan et al., 2022), we found that episodic and relational memory was (a) significantly negatively associated with the CAIDE risk score, (b) positively associated with stimulating lifestyle activities, and (c) that females performed significantly better than males in episodic and relational memory. The key novel finding of this study was that inherited dementia risk (i.e., APOE Ɛ4 genotype) modulated the association between sex, lifestyle and cognition. Only for APOE Ɛ4+ females, not APOE Ɛ4-, higher occupational attainment was associated with better episodic and relational memory. Conversely, only for APOE Ɛ4+ males, not APOE Ɛ4-, higher occupational attainment was associated with worse episodic and relational memory. These findings suggest that modifiable lifestyle activities offset cognitive decrements due to inherited AD risk in mid-life and support the targeting of modifiable lifestyle activities for the prevention of Alzheimer’s disease. Furthermore, these findings suggest an urgent need for targeted research on female-specific risk factors, to inform personalised strategies for AD prevention and the promotion of female brain health.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by the UK Alzheimers Society (Grant nos. 178, 264 and 397), the US Alzheimers Association (grant number TriBEKa-17-519007) and philanthropic donations.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:NHS Research Ethics Committee of London Camberwell St Giles gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors ER -